GSG Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.32M Buy
9,496
+133
+1% +$31K 0.6% 26
2025
Q4
$1.94M Buy
9,363
+225
+2% +$44.5K 0.5% 28
2025
Q3
$1.7M Buy
9,138
+254
+3% +$43.5K 0.45% 33
2025
Q2
$1.36M Buy
8,884
+3,701
+71% +$569K 0.39% 37
2025
Q1
$782K Buy
5,183
+367
+8% +$57.4K 0.26% 49
2024
Q4
$696K Sell
4,816
-1,157
-19% -$179K 0.22% 54
2024
Q3
$968K Buy
5,973
+257
+4% +$40.9K 0.32% 40
2024
Q2
$837K Buy
5,716
+5
+0.1% +$744 0.3% 44
2024
Q1
$881K Buy
5,711
+190
+3% +$30.2K 0.32% 41
2023
Q4
$889K Buy
5,521
+1,686
+44% +$259K 0.33% 40
2023
Q3
$597K Buy
+3,835
New +$633K 0.29% 43

Other funds holding JNJ

GSG Advisors's JNJ Position: Q1 2026 in Review

GSG Advisors increased its Johnson & Johnson (JNJ) stake by 1.4% in Q1 2026, buying an estimated $31K and bringing the position to 9,496 shares worth $2.32M. The position accounts for 0.6% of the portfolio, ranked #26.

GSG Advisors first reported a position in JNJ in Q3 2023 and has held it in 11 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • GSG Advisors held 9,496 shares of Johnson & Johnson worth $2.32M as of Q1 2026.
  • GSG Advisors bought 133 Johnson & Johnson shares in Q1 2026, an estimated $31K.
  • Johnson & Johnson made up 0.6% of GSG Advisors's portfolio in Q1 2026, its #26 holding.
  • GSG Advisors first reported a position in Johnson & Johnson in Q3 2023 and has held it in 11 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on GSG Advisors's 13F filing for Q1 2026, filed 13 May 2026.